NCT00319592View on ClinicalTrials.gov

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

ChimeriVax™-JE vaccine

0.5 mL, subcutaneously

BIOLOGICAL

JE-VAX® vaccine

1.0 mL, subcutaneously

Trial Locations (1)

66219

Clinical Pharamacology Center, Lenexa

Sponsors

Lead Sponsor

Sanofi

Collaborators (1)

PRA Health Sciences
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

Sanofi

INDUSTRY